CATX- Perspective Therapeutics, Inc.

Name: Perspective Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Perspective Therapeutics, Inc. (CATX) has 8 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. CATX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Spoor Johan M.	735.0K	$2.21M	-
CFO	Sendek Joel	600.0K	$1.80M	-
Other	Puhlmann Markus	150.0K	$450.0K	-
Other	Hunt Jonathan Robert	90.0K	$270.0K	-
Dir	Martinez Maria E	75.0K	$225.0K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 8, 2022	Hunt Jonathan Robert61	Chief Financial Officer	Buy	39,000	$0.29	$11,160.86	+26.4%	+18.1%	+83.7%
Jun 7, 2022	Woods Lori A70	CEO	Buy	75,000	$0.30	$22,230.00	+7.7%	+23.3%	+94.3%
Nov 30, 2020	Woods Lori A70	CEO	Buy	68,000	$0.38	$25,534.00	+12.5%	-	-
Oct 22, 2020	Vitale Philip J	Director	Buy	20,000	$0.52	$10,400.00	+18.2%	-	-
Oct 22, 2020	Austin Mark John	Controller/ Prin Fin&Acct Offic	Buy	19,230	$0.52	$9,999.60	+120.2%	-	-
Oct 22, 2020	Krachon Michael	EVP Of Sales &Marketing	Buy	28,844	$0.52	$14,998.88	+52.4%	-	-
Oct 22, 2020	Hunt Jonathan Robert61	Chief Financial Officer	Buy	67,306	$0.52	$34,999.12	New	-	-
Oct 22, 2020	Cavanagh William	Chief R&D Officer	Buy	7,692	$0.52	$3,999.84	+38.5%	-	-
Oct 22, 2020	Woods Lori A70	CEO	Buy	48,076	$0.52	$24,999.52	New	-	-
Oct 22, 2020	Hoffmann Alan	Director	Buy	19,230	$0.52	$9,999.60	New	-	-

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC